MedTrace Logo

Clinical Investigation to Assess the Feasibility of a New Diabetes Management Program

NCT05793645 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-07-20

No results posted yet for this study

Summary

The goal of this interventional study is to assess the adherence to a personalized care plan in patients (12-15 years) with Type 1 diabetes

Conditions

Interventions

DEVICE

personalized care plan

Algorithm that defines personalized care plan

Sponsors & Collaborators

  • Key2Compliance

    collaborator INDUSTRY

  • NordicInfu Care AB

    collaborator INDUSTRY

  • Air Liquide Santé International

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-15
Primary Completion
2024-01-30
Completion
2024-03-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05793645 on ClinicalTrials.gov